soul trial oral semaglutide cardiovascular outcomes trial benefit study in High-Risk Type 2 Diabetes: Confirmed in the Scorecard: SOUL – Oral Semaglutide in High-Risk Type – Abstract 4367751: Cardiovascular Outcomes of
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12



























